drugset / Trial / NCT00865748
A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions
RandomizedCrossoverOpen-label
Summary
The purpose of this study is compare the relative bioavailability of 500 mg Metformin Hydrochloride Extended Release Tablets by Alpharma with that of 500 mg CLUCOPHAGE® XR Tablets distributed by Bristol-Myers Squibb Company following a single oral dose (1 x 500 mg extended-release tablet) in healthy adult volunteers under fasting conditions.
Timeline
- Start
- 2004-01
- Primary completion
- 2004-01
- Completion
- 2004-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 500 mg | Oral |
Indications
No indication recorded.